Mevlüde İnanç

Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial

Robin Kate Kelley, Makoto Ueno, Changhoon Yoo et al. · The Lancet · 2023 · 891 citations · Full text

Urology, Surgical Oncology, Gastrointestinal Oncology +5

Prognostic factors for teenage and adult patients with high-grade osteosarcoma: an analysis of 240 patients

Ayşe Durnalı, Şengül Cangür, Fisun Ardıç Yükrük et al. · Medical Oncology · 2013 · 79 citations · Full text

Prognostic Factors, Adult Patients, High-grade Osteosarcoma +4

Cytokeratin 5/6, c-Met expressions, and PTEN loss prognostic indicators in triple-negative breast cancer

Mevlüde İnanç, Metin Özkan, Halıt Karaca et al. · Medical Oncology · 2013 · 61 citations

C-met Expressions, Prognostic Biomarkers, Breast Oncology +11

Prognostic factors and clinical outcome of patients with Ewing’s sarcoma family of tumors in adults: multicentric study of the Anatolian Society of Medical Oncology

Erkan Arpacı, Tarkan Yetişyiğit, Metin Şeker et al. · Medical Oncology · 2013 · 51 citations

Prognostic Factors, Surgical Oncology, Tumoral Pathology +8

Clinical outcomes in patients who received lapatinib plus capecitabine combination therapy for HER2-positive breast cancer with brain metastasis and a comparison of survival with those who received trastuzumab-based therapy: a study by the Anatolian Society of Medical Oncology

Abdurrahman Işıkdoğan, Doğan Koca, Mehmet Küçüköner et al. · Breast Cancer · 2013 · 38 citations

Breast Oncology, Capecitabine Combination Therapy, Medicine +7